SCHEMBL2467263

SCHEMBL2467263

COC(=O)c1cccnc1[AsH2]

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.54
PKM P14618 1/20 0.54
MAP2K1 Q02750 1/20 0.53
KDM4E B2RXH2 5/20 0.51
POLB P06746 2/20 0.50
ATM Q13315 1/20 0.50
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48
ALDH1A1 P00352 5/20 0.47
CFTR P13569 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CNR2 P34972 1/20 0.47
ALOX15 P16050 1/20 0.45
HTT P42858 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812065 0.81 KDM4E (0.59) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL107721 0.79 KDM4E (0.57) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL27819878 0.79 P2RX7 (0.66) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL162558 0.79 TDP1 (0.57) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL31185958 0.79 KDM4E (0.57) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL69990 0.79 L3MBTL1 (0.62) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL29416324 0.79 L3MBTL1 (0.62) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL1248162 0.79 P2RX7 (0.66) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL111436 0.78 TDP1 (0.55) TDP1L3MBTL1PKMMAP2K1KDM4E
SCHEMBL1807370 0.78 TDP1 (0.55) TDP1L3MBTL1PKMMAP2K1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110213156-A1 5-MEMBERED HETEROCYCLIC COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213156-A1 5-MEMBERED HETEROCYCLIC COMPOUND RXRA, RXRG, RXRB TDP1 4723/4885L3MBTL1 4273/4885PKM 2977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.